Akbar Khan is the founder and Medical Director of Medicor Cancer Centres.
For the last 21 years, his
primary practice has consisted of providing personalized care by focusing on a limited number of cancer patients.
This has given him extensive experience in dealing with the unique, complex and varied issues that cancer patients and their families face.
has always been active and innovative in the field of cancer care.
In 1999, he co-founded P.A.L.I.N., a registered charitable corporation which addressed the needs of cancer patients requiring at-home symptom control and enhanced quality of life.
Since 2007, Dr. Khan
gained international recognition and has been treating patients from all over the world due to his
unique non-toxic approaches to cancer treatment.
is privileged to be the first doctor in the world to prescribe off-label� DCA to treat cancer with positive results.
As a result, he now has the most DCA experience of any physician in the world with over 1500 cancer patients treated.
also has taken the refreshing approach of openly sharing the results of his
treatments with the not just the medical community, but with the public through this website in the form of observational data and case reports.
This allows patients and physicians everywhere to benefit from his
knowledge, and learn to use DCA safely and effectively.
In 2013, Dr . Khan
was honoured to be contacted by Dr. Ken Matsumura of Berkeley California, with the news that Medicor
was selected to be the first Canadian clinic to offerS.E.F. Chemotherapy*, a unique and powerful chemo-immunotherapy.
Although Dr. Khan
first discovered Dr. Matsumura's amazing research in 2006, a S.E.F. Chemo clinical trial was still under way at the time, so the therapy could not be given in Canada. After completion of the trial, Dr. Matsumura began preparation to open a new satellite clinic.
Through ongoing advancement, Dr. Khan
has created a cancer clinic which allows patients to receive optimized care by integrating conventional, naturopathic and off-label therapies.
is constantly exploring unique and cutting edge solutions to the varied problems that cancer patients and their families face on a day-to-day basis.
compassion and willingness to work with patients' unique needs make him the ideal leader of Medicor Cancer Centres'
* S.E.F. chemo ("Side Effect Free" chemo, pronounced "safe" chemo) is a servicemark of the Berkeley Institute International
Dr. Khan's Curriculum Vitae
Fun Page- our Medical Director shares something personal.
Dr. Khan's Publications
A Novel Form of Dichloroacetate Therapy for Patients With Advanced Cancer: A Report of 3 Cases.
Khan A, Marier D, Marsden E, Andrews D, Eliaz I., Altern Ther Health Med.
A, J Palliat Med.
2011 Apr 12. [Epub ahead of print]